The global crisis of visual impairment: an emerging global health priority requiring urgent action

John-Ross Rizzo,Mahya Beheshti,Todd E. Hudson,Pattanasak Mongkolwat,Wachara Riewpaiboon,William Seiple,Olugbenga G. Ogedegbe,Rajesh Vedanthan

DOI: https://doi.org/10.1080/17483107.2020.1854876

2020-12-17

Abstract:In 2010, the World Health Organisation (WHO) reported 733 million people with visual impairment (VI) world-wide and predicted an increase to 929 million by 2020 [<span class="ref-lnk lazy-ref"><a href="#">1</a></span>]. Their updated report from late 2019 revealed a massive 2.2 billion people with VI or blindness, far exceeding their prior expectation [<span class="ref-lnk lazy-ref"><a href="#">2</a></span>]. In 2003, the World Health Service survey conducted in 70 countries across 6 continents found that, in low- and middle-income countries (LMICs), 23–24% of adults reported visual difficulty, whereas, in high-income countries, the rate was 13%. It was also reported that 5–6% of adults in LMICs suffered from severe to extreme visual difficulty, whereas in high-income countries (HICs) the rate was 2% [<span class="ref-lnk lazy-ref"><a href="#">3</a></span>]. This uneven distribution of prevalence and burden appears secondary to insufficient access to health care and rehabilitative support services [<span class="ref-lnk lazy-ref"><a href="#">2</a></span>]. Recent results of studies in LMICs highlighted the lack of access to healthcare services, medical rehabilitation (e.g., vision rehab) and assistive devices [<span class="ref-lnk lazy-ref"><a href="#">4–7</a></span>]. The delay in needed medical evaluations and preventive care inevitably leads to increases in both correctable and uncorrectable VI with concomitant increases in the economic burden on social and medical systems. The total health care expenditure was forecasted to be $2.77 trillion in 2020, a rise from $2.30 trillion in 2010[<span class="ref-lnk lazy-ref"><a href="#">8</a></span>]. In addition, the WHO reported that the global economic impact associated with just absenteeism and productivity loss, indirect medical costs, would be $176 billion in 2020 [<span class="ref-lnk lazy-ref"><a href="#">8</a></span>].